Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I
✍ Scribed by S�ndergaard, Knud ;Schou, Geert
- Publisher
- Springer-Verlag
- Year
- 1985
- Tongue
- English
- Weight
- 575 KB
- Volume
- 408
- Category
- Article
- ISSN
- 0174-7398
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The authors have studied the natural history of 377 patients with Stage I cutaneous malignant melanoma followed at the Arizona Cancer Center, Tucson. Two hundred eight patients, or 55%, remained free of metastatic disease after a median follow-up of 30 months. The survival at 5,8, and 10 years was 6
During the period [1965][1966][1967][1968][1969][1970][1971][1972][1973][1974] 110 patients with stage I malignant melanoma of the extremities were treated by regional isolated perfusion with L-phenylalanine mustard and local excision. In order to study local recurrence and survival, only patients w